Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,293 | 135 | 53.4% |
| Travel and Lodging | $3,689 | 15 | 45.9% |
| Education | $52.99 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AERIN MEDICAL INC. | $1,778 | 12 | $0 (2024) |
| Intersect ENT, Inc. | $1,752 | 7 | $0 (2017) |
| Stryker Corporation | $1,501 | 16 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,010 | 39 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $661.31 | 26 | $0 (2024) |
| GENZYME CORPORATION | $595.39 | 15 | $0 (2024) |
| Optinose US, Inc. | $380.06 | 20 | $0 (2024) |
| Genentech USA, Inc. | $81.34 | 1 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $52.99 | 1 | $0 (2024) |
| Medtronic, Inc. | $40.24 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,661 | 40 | AERIN MEDICAL INC. ($1,729) |
| 2023 | $2,343 | 43 | Stryker Corporation ($1,060) |
| 2022 | $982.90 | 45 | GlaxoSmithKline, LLC. ($324.64) |
| 2021 | $129.53 | 9 | Regeneron Healthcare Solutions, Inc. ($100.06) |
| 2020 | $15.51 | 1 | Medtronic USA, Inc. ($15.51) |
| 2019 | $26.11 | 2 | ALK-Abello, Inc ($26.11) |
| 2018 | $29.53 | 2 | Medtronic USA, Inc. ($18.41) |
| 2017 | $1,847 | 9 | Intersect ENT, Inc. ($1,752) |
All Payment Transactions
151 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Immunology | ||||||
| 12/04/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $52.99 | General |
| Category: Immunology | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/18/2024 | Stryker Corporation | SCOPIS ENT (Device) | Food and Beverage | In-kind items and services | $157.15 | General |
| Category: INSTRUMENTS | ||||||
| 08/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: IMMUNOLOGY | ||||||
| 08/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Immunology | ||||||
| 07/24/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device) | Travel and Lodging | In-kind items and services | $140.05 | General |
| Category: EAR NOSE & THROAT | ||||||
| 07/24/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 06/24/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: IMMUNOLOGY | ||||||
| 06/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Immunology | ||||||
| 06/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $121.53 | General |
| Category: Immunology | ||||||
| 05/22/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 05/13/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: IMMUNOLOGY | ||||||
| 04/30/2024 | Medtronic, Inc. | PROPEL (Device) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 04/24/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: IMMUNOLOGY | ||||||
| 04/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Immunology | ||||||
| 04/10/2024 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 03/31/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device) | Travel and Lodging | In-kind items and services | $258.32 | General |
| Category: EAR NOSE & THROAT | ||||||
| 03/31/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device) | Food and Beverage | In-kind items and services | $50.03 | General |
| Category: EAR NOSE & THROAT | ||||||
| 03/26/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $6.85 | General |
| Category: IMMUNOLOGY | ||||||
| 03/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Immunology | ||||||
| 03/13/2024 | Stryker Corporation | SCOPIS ENT (Device) | Food and Beverage | In-kind items and services | $175.00 | General |
| Category: INSTRUMENTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 402 | 642 | $245,223 | $59,216 |
| 2022 | 15 | 1,256 | 1,816 | $872,998 | $209,028 |
| 2021 | 20 | 1,852 | 3,390 | $1.1M | $359,876 |
| 2020 | 18 | 1,369 | 2,052 | $731,560 | $224,472 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 68 | 118 | $75,387 | $18,877 | 25.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 110 | 217 | $63,629 | $14,800 | 23.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 110 | $45,561 | $11,032 | 24.2% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 31 | 48 | $20,915 | $5,387 | 25.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 59 | 59 | $21,495 | $5,253 | 24.4% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 64 | 79 | $12,316 | $2,386 | 19.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $5,921 | $1,482 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 360 | 615 | $259,897 | $60,163 | 23.1% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 222 | 353 | $234,265 | $58,041 | 24.8% |
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Office | 2022 | 21 | 62 | $80,228 | $21,119 | 26.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 122 | 122 | $67,086 | $15,649 | 23.3% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 81 | 115 | $51,845 | $12,322 | 23.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 102 | 150 | $45,426 | $11,540 | 25.4% |
| 31238 | Control of bleeding of nose using an endoscope | Office | 2022 | 24 | 39 | $33,182 | $8,372 | 25.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 88 | 88 | $32,994 | $8,037 | 24.4% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 154 | 174 | $27,679 | $5,332 | 19.3% |
| 31267 | Removal of nasal sinus tissue using an endoscope | Facility | 2022 | 11 | 11 | $16,573 | $2,844 | 17.2% |
| 31579 | Exam to assess movement of vocal cord flaps using an endoscope | Office | 2022 | 15 | 15 | $10,126 | $2,268 | 22.4% |
| 61782 | Computer-assisted procedure outside membrane covering brain | Facility | 2022 | 11 | 11 | $6,202 | $1,624 | 26.2% |
| 95992 | Repositioning exercises of head for treatment of dizziness, each day | Office | 2022 | 13 | 26 | $3,735 | $942.51 | 25.2% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2022 | 15 | 15 | $2,641 | $486.39 | 18.4% |
| 92567 | Test to assess middle ear function | Office | 2022 | 17 | 20 | $1,118 | $288.49 | 25.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 535 | 1,249 | $352,126 | $138,958 | 39.5% |
| 31231 | Diagnostic examination of nasal passages using an endoscope | Office | 2021 | 261 | 488 | $262,462 | $87,699 | 33.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 223 | 223 | $72,941 | $31,077 | 42.6% |
About Dr. Gregory Smith, M.D
Dr. Gregory Smith, M.D is a Otolaryngology healthcare provider based in Evesham, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/15/2010. The National Provider Identifier (NPI) number assigned to this provider is 1730405762.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Smith, M.D has received a total of $8,035 in payments from pharmaceutical and medical device companies, with $2,661 received in 2024. These payments were reported across 151 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($4,293).
As a Medicare-enrolled provider, Smith has provided services to 4,879 Medicare beneficiaries, totaling 7,900 services with total Medicare billing of $852,593. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Otolaryngology
- Location Evesham, NJ
- Active Since 04/15/2010
- Last Updated 05/17/2023
- Taxonomy Code 207Y00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1730405762
Products in Payments
- PROPEL (Device) $1,792
- VIVAER STYLUS (Device) $1,760
- DUPIXENT (Biological) $1,296
- SCOPIS ENT (Device) $1,291
- NUCALA (Biological) $1,010
- Xhance (Drug) $380.06
- XPRESS ENT DILATION SYSTEM (Device) $185.01
- Activase (Biological) $81.34
- NUVENT (Device) $33.92
- XIFAXAN (Drug) $29.47
- Odactra (Drug) $26.11
- AUDION ET DILATION SYSTEM (Device) $25.54
- Ryaltris (Drug) $14.56
- CINRYZE (Drug) $13.98
- LIBTAYO (Biological) $13.67
- BREATHTEK (Device) $11.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.